Dynamic intervention-based biomarkers may reduce heterogeneity and motivate targeted interventions in clinical high risk for psychosis
Niznikiewicz, M.A., R.O. Brady, S. Whitfield-Gabrieli, M.S. Keshavan, T. Zhang, Li, O. Pasternak, M.E. Shenton, J. L. Wang, and W.S. Stone. 2022. “Dynamic Intervention-Based Biomarkers May Reduce Heterogeneity and Motivate Targeted Interventions in Clinical High Risk for Psychosis”. Schizophrenia Research 246: 60-62.